循環器ジャーナル68巻1号

2020年01月発行

特集 U40世代が描く心不全診療の現状と未来—基礎研究を識り，臨床を素心深考する

Ⅰ．心筋症

—基礎編—虚血性心筋症：急性心筋梗塞後のリモデリングの規定因子とリモデリングを抑制する方法はありますか？

著者： 高橋佑典¹ 木岡秀隆¹ 坂田泰史¹

所属機関： ¹大阪大学大学院医学系研究科循環器内科学

ページ範囲：P.36 - P.40

文献概要

Point
・心筋梗塞後の左室リモデリングは，梗塞領域の創傷治癒にかかわる早期リモデリングと慢性期の左室機能低下にかかわる後期リモデリングに分けられる．
・早期リモデリングには炎症と組織修復という2相性の反応が必要で，不十分な創傷治癒や過剰な炎症は，後期リモデリングをも増悪させる．
・早期リモデリングに着目した，免疫細胞や心筋代謝に介入する新規治療法の臨床応用が期待される．

参考文献

1) Prabhu SD, Frangogiannis NG:The Biological Basis for Cardiac Repair After Myocardial Infarction:From Inflammation to Fibrosis. Circ Res 119:91-112, 2016

2) Bhatt AS, Ambrosy AP, Velazquez EJ:Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep 19:71, 2017

3) Shinde AV, Frangogiannis NG:Fibroblasts in myocardial infarction:a role in inflammation and repair. J Mol Cell Cardiol 70:74-82, 2014

4) Niccoli G, Montone RA, Ibanez B, et al:Optimized Treatment of ST-Elevation Myocardial Infarction. Circ Res 125:245-258, 2019

5) Hamirani YS, Wong A, Kramer CM, et al:Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction:a systematic review and meta-analysis. JACC Cardiovasc Imaging 7:940-952, 2014

6) Weir RA, Murphy CA, Petrie CJ, et al:Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging 3:360-367, 2010

7) Maekawa Y, Anzai T, Yoshikawa T, et al:Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 44:1510-1520, 2004

8) Anzai A, Anzai T, Nagai S, et al:Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125:1234-1245, 2012

9) Weirather J, Hofmann UD, Beyersdorf N, et al:Foxp3＋CD4＋T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res 115:55-67, 2014

10) Takahashi T, Anzai T, Yoshikawa T, et al:Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction--role of neurohormones and cytokines. Int J Cardiol 88:257-265, 2003

11) Anzai T, Yoshikawa T, Shiraki H, et al:C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction.

12) McCartney PJ, Eteiba H, Maznyczka AM, et al:Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction:A Randomized Clinical Trial. JAMA 321:56-68, 2019

13) Esposito ML, Zhang Y, Qiao X, et al:Left Ventricular Unloading Before Reperfusion Promotes Functional Recovery After Acute Myocardial Infarction. J Am Coll Cardiol 72:501-514, 2018

14) O'Neill WW, Grines C, Schreiber T, et al:Analysis of outcomes for 15, 259 US patients with acute myocardial infarction cardiogenic shock（AMICS）supported with the Impella device. Am Heart J 202:33-38, 2018

15) Kapur NK, Alkhouli MA, DeMartini TJ, et al:Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction. Circulation 139:337-346, 2019

16) Götberg M, Olivecrona GK, Engblom H, et al:Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord 8:7, 2008

17) Erlinge D, Götberg M, Lang I, et al:Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial:a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol 63:1857-1865, 2014

18) Dae M, O'Neill W, Grines C, et al:Effects of endovascular cooling on infarct size in ST-segment elevation myocardial infarction:A patient-level pooled analysis from randomized trials. J Interv Cardiol 31:269-276, 2018

19) Phillips BE, Garciafigueroa Y, Trucco M, et al:Clinical Tolerogenic Dendritic Cells:Exploring Therapeutic Impact on Human Autoimmune Disease. Front Immunol 8:1279, 2017

20) Choo EH, Lee JH, Park EH, et al:Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Regulatory T Cell and Macrophage Polarization. Circulation 135:1444-1457, 2017